BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29651002)

  • 1. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.
    Chang HH; Moro A; Chou CEN; Dawson DW; French S; Schmidt AI; Sinnett-Smith J; Hao F; Hines OJ; Eibl G; Rozengurt E
    Sci Rep; 2018 Apr; 8(1):5899. PubMed ID: 29651002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.
    Dong TS; Chang HH; Hauer M; Lagishetty V; Katzka W; Rozengurt E; Jacobs JP; Eibl G
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G763-G772. PubMed ID: 31545922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.
    Chang HH; Moro A; Takakura K; Su HY; Mo A; Nakanishi M; Waldron RT; French SW; Dawson DW; Hines OJ; Li G; Go VLW; Sinnett-Smith J; Pandol SJ; Lugea A; Gukovskaya AS; Duff MO; Rosenberg DW; Rozengurt E; Eibl G
    PLoS One; 2017; 12(9):e0184455. PubMed ID: 28886117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
    Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
    Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
    Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
    Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.
    Mohammed A; Janakiram NB; Li Q; Madka V; Ely M; Lightfoot S; Crawford H; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1417-26. PubMed ID: 21084261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote Kras
    Zhao Y; Schoeps B; Yao D; Zhang Z; Schuck K; Tissen V; Jäger C; Schlitter AM; van der Kammen R; Ludwig C; D'Haese JG; Raulefs S; Maeritz N; Shen S; Zou X; Krüger A; Kleeff J; Michalski CW; Friess H; Innocenti M; Kong B
    Gastroenterology; 2021 Apr; 160(5):1755-1770.e17. PubMed ID: 33388318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model.
    Dawson DW; Hertzer K; Moro A; Donald G; Chang HH; Go VL; Pandol SJ; Lugea A; Gukovskaya AS; Li G; Hines OJ; Rozengurt E; Eibl G
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1064-73. PubMed ID: 23943783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
    PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases.
    Liou GY; Byrd CJ; Storz P; Messex JK
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer.
    Hertzer KM; Xu M; Moro A; Dawson DW; Du L; Li G; Chang HH; Stark AP; Jung X; Hines OJ; Eibl G
    Pancreas; 2016 Mar; 45(3):458-65. PubMed ID: 26495779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
    Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
    Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
    Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
    [No Abstract]   [Full Text] [Related]  

  • 19. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.
    Eibl G; Rozengurt E
    Semin Cancer Biol; 2019 Feb; 54():50-62. PubMed ID: 29079305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.